Bioharvest Sciences Inc
CNSX:BHSC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Bioharvest Sciences Inc
Total Current Liabilities
Bioharvest Sciences Inc
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bioharvest Sciences Inc
CNSX:BHSC
|
Total Current Liabilities
$2.9m
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
High Tide Inc
XTSX:HITI
|
Total Current Liabilities
CA$93.8m
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Canopy Growth Corp
TSX:WEED
|
Total Current Liabilities
CA$98.3m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
35%
|
|
|
Aurora Cannabis Inc
TSX:ACB
|
Total Current Liabilities
CA$145.9m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
34%
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Total Current Liabilities
CA$92.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Total Current Liabilities
$48.2m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
40%
|
|
Bioharvest Sciences Inc
Glance View
BioHarvest Sciences, Inc. develops bio farming technology. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-08-05. The firm operates through two segments: Superfruits and Cannabis. The Superfruits segment is engaged in the development, design, manufacture and marketing of VINIA for the retail market. The Cannabis segment is focused on the development, design, manufacture and marketing of medical cannabis. Its nutraceutical superfruits product, VINIA, is made of red grape (Vitis vinifera) cells grown in the Company's bioreactor facility. The firm is also engaged in research and development of its BioFarming technology for use in the cannabis industry. This plant-based technology produces cannabis cells. The firm is engaged in the sales of VINIA in the Israeli and United States markets. Its subsidiaries include BioHarvest Inc., Dolarin Ltd. (Dolarin) and Superfood Nutraceuticals Inc. (Superfood).
See Also
What is Bioharvest Sciences Inc's Total Current Liabilities?
Total Current Liabilities
2.9m
USD
Based on the financial report for Dec 31, 2023, Bioharvest Sciences Inc's Total Current Liabilities amounts to 2.9m USD.
What is Bioharvest Sciences Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 3Y
16%
Over the last year, the Total Current Liabilities growth was 0%. The average annual Total Current Liabilities growth rates for Bioharvest Sciences Inc have been 16% over the past three years .
